Researchers have identified a significant breakthrough in understanding persistent HIV traces detected in patients receiving effective antiretroviral therapy. Using advanced molecular techniques, scientists discovered that most low-level viral detections originate from defective viral copies rather than infectious, replication-competent virus. This finding addresses a longstanding clinical challenge that has created unnecessary anxiety among patients and uncertainty for healthcare providers interpreting viral load results. The research demonstrates that successful treatment adherence can indeed suppress infectious HIV, even when trace amounts of non-infectious viral material remain detectable in blood samples. These insights could fundamentally reshape clinical interpretation protocols and provide reassurance to the vast majority of treated patients who maintain undetectable or suppressed viral loads. Read the full article on GMJ Newsroom.
Was this article helpful?
